The Influenza Virus Vaccine, cataloged under National Stock Number 6505-01-706-4494, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Sanofi Pasteur Inc.. Government technical data includes 4 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-706-4494 |
| Primary Part Number | NDC49281-0123-65 |
| Item Name | Influenza Virus Vaccine |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Sanofi Pasteur Inc. |
| Status | ACTIVE |
| Immediate Container Type | SYRINGE |
| Virus Strain | FLU VIRUS |
| Valence | QUADRIVALENT |
| Protective Storage Feature | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC49281-0123-65 PRIMARY | Sanofi Pasteur Inc. (USA) |
| Reference | Meaning |
|---|---|
| FLUZONE HIGH DOSE 2023/2024 | 3/1 Design control — primary reference Sanofi Pasteur Inc. |
| 6505NCM228749 | 5/1 Secondary reference Defense Medical Standardization Board |
| 1641096 | 5/1 Secondary reference U.S. Government activity |
NSN 6505-01-706-4494 is a Influenza Virus Vaccine, manufactured by Sanofi Pasteur Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-706-4494 has 1 manufacturer part number on file: NDC49281-0123-65 (Sanofi Pasteur Inc.).
Key specifications for NDC49281-0123-65: Immediate Container Type: SYRINGE; Virus Strain: FLU VIRUS; Valence: QUADRIVALENT; Special Features: 0.7 ML SINGLE DOSE PREFILLED SYRINGE PG OF 10 (W/O NEEDLES) INACTIVATED INFLUENZA VACCINE FOR FLU SEASON 2023-2024. FOR IMMUNIZING PERSONS 65 YEARS OF AGE AND OLDER; FOR IM ADMINISTRATION; PRESERVATIVE FREE; REQUIRES REFRIG BTWN 2-8 DEC C; DO NOT FREEZE. 2023-2024 INFLUENZA VACCINE STRAINS: A/VICTORIA/4897/2022 (H1N1)PDM09-LIKE VIRUS; AN A/DARWIN/9/2021 (H3N2)-LIKE VIRUS; AND A B/AUSTRIA/1359417/2021 (B/VICTORIA LINEAGE)-LIKE VIRUS; AND A B/PHUKET/3073/2013 (B/YAMAGATA LINEAGE)-LIKE VIRUS.. 4 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.